# Trade Execution Log

**Model:** ChatGPT
**Date:** 2026-01-21

```text

==================================================
ðŸ“Š ALPACA PRE-FLIGHT STATUS (ChatGPT)
==================================================
ðŸ’° Equity: $975.02
ðŸ’¸ Buying Power: $343.40

ðŸ“‚ Current Positions:
   â€¢ APLD: 3 shares @ $35.06 (Current: $35.41)
   â€¢ NVAX: 14 shares @ $7.44 (Current: $9.08)
   â€¢ RXRX: 14 shares @ $4.70 (Current: $4.61)
   â€¢ SLS: 29 shares @ $3.83 (Current: $4.29)
   â€¢ UAA: 14 shares @ $5.78 (Current: $6.03)

ðŸ“ Open Orders:
   â€¢ SLS: LIMIT SELL 29 shares @ $4.94 (new)
   â€¢ SLS: STOP SELL 29 shares Stop @ $3.50 (OCO-held)
   â€¢ LENZ: LIMIT BUY 7 shares @ $17.90 (new)
   â€¢ LENZ: STOP SELL 7 shares Stop @ $16.00 (OCO-held)
   â€¢ LENZ: LIMIT SELL 7 shares @ $24.00 (OCO-held)

==================================================

ðŸ“‹ Parsing Portfolio Recommendation from Clipboard...
--------------------
ðŸ“‹ CLIPBOARD CONTENT:
| ACTION | TICKER | QTY | TYPE  | LIMIT_PRICE | STOP_LOSS | TAKE_PROFIT | REASON                                                          |
| :----- | :----- | :-: | :---- | :---------: | :-------: | :---------: | :-------------------------------------------------------------- |
| HOLD   | APLD   |  3  | N/A   |     N/A     |    N/A    |     N/A     | Facility outage is temporary; AI buildout thesis intact         |
| HOLD   | NVAX   |  14 | N/A   |     N/A     |    N/A    |     N/A     | Pfizer licensing deal boosts outlook                            |
| HOLD   | RXRX   |  14 | N/A   |     N/A     |    N/A    |     N/A     | No new negatives; pipeline focus remains unchanged              |
| CANCEL | SLS    |  29 | N/A   |     N/A     |    N/A    |     N/A     | Pending sell @4.94 stale (last ~$4.30, >10% away)               |
| HOLD   | SLS    |  29 | N/A   |     N/A     |    N/A    |     N/A     | Expanded AML trial collaboration with IMPACT-AML                |
| HOLD   | UAA    |  14 | N/A   |     N/A     |    N/A    |     N/A     | Recent strong rebound, no adverse news                          |
| BUY    | SMCI   |  7  | LIMIT |      32     |     30    |      36     | Short interest ~17.1%, above 20/50â€‘SMAs; earnings 2/24 catalyst |
--------------------

ðŸ”Ž Found 8 trade(s) (Markdown table).

âœ‹ HOLDING: APLD (No stop-loss specified)

âœ‹ HOLDING: NVAX (No stop-loss specified)

âœ‹ HOLDING: RXRX (No stop-loss specified)

ðŸš« PROCESSING CANCEL: SLS
   ðŸ§¹ Cancelling 2 active order(s) for SLS...
   âœ… Cancelled order 6b1c6408-59bb-44b3-bc77-9a2b5fc17f8e
   âœ… Cancelled order 835c85ea-3eb1-49d4-b94a-9c8ed43cf3fb
   âœ… All orders for SLS successfully cancelled.

âœ‹ HOLDING: SLS (No stop-loss specified)

âœ‹ HOLDING: UAA (No stop-loss specified)

ðŸš€ PROCESSING BUY: SMCI
   Order: BUY 7 SMCI @ $32.00 (SL: $30.00, TP: $36.00) (Est. Cost: $224.00)
   âœ… SUCCESS: Buy order placed!
```
